| [1] |
Parvizi J, Fassihi SC, Enayatollahi MA. Diagnosis of periprosthetic joint infection following hip and knee arthroplasty[J]. Orthop Clin North Am, 2016, 47(3): 505-515.
|
| [2] |
Salvati EA, Gonzalez Della Valle A, Masri BA, et al. The infected total hip arthroplasty[J]. Instr Course Lect, 2003, 52: 223-245.
|
| [3] |
Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States[J/OL]. J Arthroplasty, 2012, 27(8 Suppl): 61-5.e1. doi: 10.1016/j.arth.2012.02.022. |
| [4] |
Berend KR, Lombardi AV, Morris MJ, et al. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality[J]. Clin Orthop Relat Res, 2013, 471(2): 510-518.
|
| [5] |
Hofmann AA. Two-stage exchange is better than direct exchange in the infected THA[J]. Orthopedics, 1999, 22(10): 918.
|
| [6] |
Engesæter LB, Dale H, Schrama JC, et al. Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register[J]. Acta Orthop, 2011, 82(5): 530-537.
|
| [7] |
Corona PS, Vicente M, Carrera L, et al. Current actual success rate of the two-stage exchange arthroplasty strategy in chronic hip and knee periprosthetic joint infection[J]. Bone Joint J, 2020, 102-B(12): 1682-1688.
|
| [8] |
Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America[J/OL]. Clin Infect Dis, 2013, 56(1): e1-e25. doi: 10.1093/cid/cis966. |
| [9] |
Kuzyk PR, Dhotar HS, Sternheim A, et al. Two-stage revision arthroplasty for management of chronic periprosthetic hip and knee infection: techniques, controversies, and outcomes[J]. J Am Acad Orthop Surg, 2014, 22(3): 153-164.
|
| [10] |
Jones CW, Selemon N, Nocon A, et al. The influence of spacer design on the rate of complications in two-stage revision hip arthroplasty[J]. J Arthroplasty, 2019, 34(6): 1201-1206.
|
| [11] |
Barreira P, Leite P, Neves P, et al. Preventing mechanical complications of hip spacer implantation: technical tips and pearls[J]. Acta Orthop Belg, 2015, 81(2): 344-348.
|
| [12] |
Anagnostakos K, Fürst O, Kelm J. Antibiotic-impregnated PMMA hip spacers: current status[J]. Acta Orthop, 2006, 77(4): 628-637.
|
| [13] |
Biring GS, Kostamo T, Garbuz DS, et al. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study[J]. J Bone Joint Surg Br, 2009, 91(11): 1431-1437.
|
| [14] |
Duncan CP, Beauchamp C. A temporary antibiotic-loaded joint replacement system for management of complex infections involving the hip[J]. Orthop Clin North Am, 1993, 24(4): 751-759.
|
| [15] |
Chalmers BP, Mabry TM, Abdel MP, et al. Two-stage revision total hip arthroplasty with a specific articulating antibiotic spacer design: reliable periprosthetic joint infection eradication and functional improvement[J]. J Arthroplasty, 2018, 33(12): 3746-3753.
|
| [16] |
Tsung JD, Rohrsheim JA, Whitehouse SL, et al. Management of periprosthetic joint infection after total hip arthroplasty using a custom made articulating spacer (CUMARS); the Exeter experience[J]. J Arthroplasty, 2014, 29(9): 1813-1818.
|
| [17] |
Zhang W, Fang X, Shi T, et al. Cemented prosthesis as spacer for two-stage revision of infected hip prostheses: a similar infection remission rate and a lower complication rate[J]. Bone Joint Res, 2020, 9(8): 484-492.
|
| [18] |
Masri B, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system[J]. J Arthroplasty, 1998, 13(3): 331-338.
|
| [19] |
Neut D, Van DH, Stokroos I, et al. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery[J]. J Antimicrob Chemother, 2001, 47(6): 885-891.
|
| [20] |
Cabo J, Euba G, Saborido A, et al. Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections[J]. J Infect, 2011, 63(1): 23-31.
|
| [21] |
Fink B, Vogt S, Reinsch M, et al. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses[J]. Clin Orthop Relat Res, 2011, 469(11): 3141-3147.
|
| [22] |
Veltman ES, Moojen DJ, Glehr M, et al. Similar rate of infection eradication for functional articulating, prefabricated and custom-made spacers in 2-stage revision of the infected total hip: a literature review[J]. Hip Int, 2016, 26(4): 319-326.
|
| [23] |
Scharfenberger A, Clark M, Lavoie G, et al. Treatment of an infected total hip replacement with the PROSTALAC system. Part 2: Health-related quality of Life and function with the PROSTALAC implant in situ[J]. Can J Surg, 2007, 50(1): 29-33.
|
| [24] |
Beaupre LA, Stampe K, Masson E, et al. Health-related quality of Life with long-term retention of the PROSthesis of antibiotic loaded acrylic cement system following infection resolution in low demand patients[J/OL]. J Orthop Surg (Hong Kong), 2017, 25(2): 2309499017716257. doi: 10.1177/2309499017716257. |